Initiatives in the Medical Field

Since first launching X-ray film in 1936, the Fujifilm Group has been engaged in the medical business for more than seven decades. Current annual sales from our Medical Systems Business, including the Life Science Business, has grown to ¥ 290 billion (fiscal 2007), nearly 10% of total Group sales.
Under VISION75, our medium-term management plan, we intend for this business to achieve ¥ 300 billion or more in sales in fiscal 2008. To this end, we are committed to focusing Group resources in this area as a core business. We are developing the division into three primary areas: examinations (using FUJI DRI-CHEM systems or diagnostic radiopharmaceuticals); diagnosis (medical imaging involving X-rays, ultrasonographs or endoscopes); and treatment (with therapeutic radiopharmaceuticals). Drawing on the strength of our global sales locations, we will deliver value to customers and contribute to the establishment of a far-reaching medical infrastructure.。